Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders - apparent relative impairment of 17,20-lyase activity

By Acien P.   Quereda F.   Matalln P.   Villarroya E.   Lopez-Fernandez J.A.   Acien M.   Mauri M.   Alfayate R.  

Fertility and Sterility, Vol. 72, Iss. 1, 1999-07 ,pp. : 32-40

Elsevier

Access to resources Recommend Favorite

Effects of metformin on body mass index, menstrual cyclicity, and ovulation induction in women with polycystic ovary syndrome

By Haas D.A.   Carr B.R.   Attia G.R.  

Fertility and Sterility, Vol. 79, Iss. 3, 2003-03 ,pp. : 469-481

Elsevier

Access to resources Recommend Favorite

Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome - comparative aspects

By De Leo V.   la Marca A.   Ditto A.   Morgante G.   Cianci A.  

Fertility and Sterility, Vol. 72, Iss. 2, 1999-08 ,pp. : 282-285

Elsevier

Access to resources Recommend Favorite

Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome

By Kolodziejczyk B.   Duleba A.J.   Spaczynski R.Z.   Pawelczyk L.  

Fertility and Sterility, Vol. 73, Iss. 6, 2000-06 ,pp. : 1149-1154

Elsevier

Access to resources Recommend Favorite

Hypothalamic-pituitary-adrenal axis sensitivity to opioids in women with polycystic ovary syndrome

By Ciampelli M.   Guido M.   Cucinelli F.   Cinque B.   Barini A.   Lanzone A.  

Fertility and Sterility, Vol. 73, Iss. 4, 2000-04 ,pp. : 712-717

Elsevier

Access to resources Recommend Favorite